Robin Garner
Stock Analyst at Craig-Hallum
(n/a)
# 3,623
Out of 4,829 analysts
4
Total ratings
n/a
Success rate
-44.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robin Garner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XERS Xeris Biopharma Holdings | Initiates: Buy | $4.5 | $4.95 | -9.09% | 2 | Aug 28, 2023 | |
| CUE Cue Biopharma | Maintains: Buy | $28 → $26 | $0.75 | +3,362.05% | 1 | Mar 18, 2022 | |
| FENC Fennec Pharmaceuticals | Initiates: Buy | $17 | $6.27 | +171.13% | 1 | Apr 21, 2021 |
Xeris Biopharma Holdings
Aug 28, 2023
Initiates: Buy
Price Target: $4.5
Current: $4.95
Upside: -9.09%
Cue Biopharma
Mar 18, 2022
Maintains: Buy
Price Target: $28 → $26
Current: $0.75
Upside: +3,362.05%
Fennec Pharmaceuticals
Apr 21, 2021
Initiates: Buy
Price Target: $17
Current: $6.27
Upside: +171.13%